血清胱抑素C联合尿RBP检验在糖尿病患者早期肾损伤中的价值

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo explore the clinical value of the joint detection of serum cystatin C(Cys C)and urinary retinol binding protcin(RBP)in the diagnosis of early renal damage for diabetic patients.Methods60 diabetic patients with early renal damage treated in our hospital from June 2015 and June 2016 were selected as the observation group,and they all underwent joint detection of serum Cys C and urinary RBP.Simultaneously,60 cases of the healthy people undergoing medical examination in our hospital were selected as the control group,and they all underwent joint detection of serum Cys C and urinary RBP.A comarison was made in serum Cys C and urinary RBP between the two groups to analyze the clinical value of in the diagnosis of early renal damage for diabetic patients.ResultsThe levels of serum Cys C and urinary RBP test results of the observation group were significantly higher than those of the control group,and the difference was statistically significant(P＜0.05).The positive rate of joint detection of serum Cys C and urinary RBP in the diagnosis of early renal injury in diabetes was significantly higher than that in single serum CysC test and urine RBP test,with significant difference(P＜0.05).ConclusionThe joint detection of serum Cys C and urinary RBP can provide reliable basis for the diagnosis of early renal damage for diabetic patients,and it is worthy of clinical promotion and application.

Key words： Diabetes Early renal injury Serum Cys C Urinary RBP

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LAI Xin

Cite this article:

LAI Xin. Value of the joint detection of serum cystatin C and retinol binding protcin in the diagnosis of early renal damage for diabetes patients[J]. 中国当代医药, 2017, 24(18): 109-110转120.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I18/109

[1]	张洪林.联合检测视黄醇结合蛋白、胱抑素C、尿微量白蛋白在早期肾损伤中的临床应用价值[J].山东医学高等专科学校学报，2014，36（1）：58-60.
[2]	王中东，黄麦华.联合检测血清 CYSC、RBP、尿 NAG 及MALB在糖尿病与高血压患者早期肾损伤中的临床应用[J].标记免疫分析与临床，2015，22（11）：1110-1112，1132.
[3]	蒋维，沈建江，郭长青.尿m-ALB、CysC和RBP联合检测在糖尿病早期肾损伤中的应用价值[J].航空航天医药，2010，9（21）：1640.
[4]	鲁丹，陈丽芳，蔡洁丹.尿RBP、NAG联合血清CysC检测在2型糖尿病早期肾损伤中的诊断价值[J].国家检验医学杂志，2016，37（7）：928-932.
[5]	单立新，高越，王学菊.血清 CysC、RBP、尿 mALb/Cr检测在糖尿病肾病早期诊断中的价值[J].天津医科大学学报，2014，20（3）：241-242.
[6]	詹鹏飞，肖俊锐，袁云燕.糖尿病肾病的前瞻性筛选研究[J].检验医学与临床，2016，13（16）：2238-2241.
[7]	陈昌达，李就文，朱耀.尿微量白蛋白与尿糖联合检测在早期糖尿病肾损伤中诊断意义[J].中国医药科学，2016，6（16）：176-179.
[8]	魏园园.血清CysC联合RBP检测在诊断早期肾损伤中的应用价值[J].吉林医学，2010，31（24）：4021-4022.
[9]	刘玉英，殷和平，蒋璐.胱抑素C联合尿RBP检测对糖尿病患者早期肾损伤的诊断意义[J].海南医学院学报，2015，21（2）：203-205.
[10]	周吕蒙.血清胱抑素C联合尿微量蛋白和视黄醇结合蛋白对早期糖尿病肾病的诊断价值[J].临床医药实践，2013，22（5）：361-363.
[11]	刘环.血清Cys-C与尿mALB联合检测在糖尿病肾病早期诊断中的应用价值[J].国际检验医学杂志，2015，36（18）：2724-2726.
[12]	魏宇鹏，张季，杨金萍.血清胱抑素C和尿中4种蛋白联合检测对早期糖尿病肾病的诊断价值[J].中国临床研究，2011，24（8）：722.
[13]	汪亮.血清Cys-C与尿mAlb/Cr联合检测对2型糖尿病早期肾损伤的诊断价值[J].国际检验医学杂志，2015，36（13）：1925-1927.
[14]	曾子荣，郭涌泉，郭亚娟.血清CysC与RBP4联合检测对糖尿病早期肾损害的诊断价值[J].基层医学论坛，2016，20（11）：1502-1503.
[15]	梁丽娟，洪宝建，方亚奇，张敏霞.血清 CysC、RBP、NEFA联合检测在2型糖尿病肾病早期诊断中的临床价值[J].中国卫生检验杂志，2015，25（4）：524-528.